Szychot, Elwira https://orcid.org/0000-0002-1598-7018
Walker, David
Collins, Peter
Hyare, Harpreet
Shankar, Ananth
Bienemann, Alison
Hollingworth, Milo
Gill, Steven
Funding for this research was provided by:
Gatsby Charitable Foundation
Funding Neuro
Lyla Nsouli Foundation
Article History
Received: 29 September 2020
Accepted: 7 December 2020
First Online: 11 February 2021
Compliance with ethical standards
:
: S. Gill was Clinical Director of Renishaw Plc. till 2020 and is a Director of XPEAD Ltd. No other author declares any conflict of interest.
: Approval for this study was obtained from the Institutional Review Board of Harley Street Children’s Hospital in London, United Kingdom, and was compliant with the 1964 Helsinki declaration and its later amendments. Patients selected for compassionate treatment obtained further approval by the UK Medicines and Healthcare Regulatory Authority (MHRA).
: Informed consent from parents/guardians was obtained for the experimental nature of the treatment and results publication.
: Verbal consent from parents/guardians was obtained for publishing the results of our study.